<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">F7cjHcvShzRsZKNrwq95rJs</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2013002700012</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(13)10100100012</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2013005000042</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Correla&#231;&#227;o da composi&#231;&#227;o de placas &#224; histologia virtual com prote&#237;na C-reativa</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Siqueira</surname>
            <given-names>Dimytri Alexandre de Alvim</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>Amanda Guerra Moraes R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa Junior</surname>
            <given-names>Jos&#233; de Ribamar</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Ricardo Alves da</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Staico</surname>
            <given-names>Rodolfo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanajura</surname>
            <given-names>Luis Fernando Leite</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Centemero</surname>
            <given-names>Marinella Patrizia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feres</surname>
            <given-names>Fausto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abizaid</surname>
            <given-names>Alexandre Antonio Cunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>J. Eduardo Moraes R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2013</year>
      </pub-date>
      <volume>101</volume>
      <issue>1</issue>
      <fpage>78</fpage>
      <lpage>86</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>02</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTOS: Estudos pr&#233;vios demonstram que o principal determinante de vulnerabilidade da placa ateroscler&#243;tica &#233; a sua composi&#231;&#227;o. Recentemente, diversos m&#233;todos de imagens e marcadores laboratoriais t&#234;m sido investigados visando identificar les&#245;es vulner&#225;veis. O ultrassom com Histologia Virtual&#174; (HV) permite a diferencia&#231;&#227;o e quantifica&#231;&#227;o dos componentes da placa. Por sua vez, a prote&#237;na C-reativa (PCR) &#233; apontada como importante preditor de eventos adversos. A correla&#231;&#227;o entre este marcador e as caracter&#237;sticas da placa n&#227;o &#233; bem estabelecida. OBJETIVOS: Avaliar a constitui&#231;&#227;o da les&#227;o culpada em pacientes com s&#237;ndrome coron&#225;ria aguda (SCA) - conforme caracterizada pela HV - e investigar a rela&#231;&#227;o dos componentes da placa com o marcador inflamat&#243;rio PCR. M&#201;TODOS: Cinquenta e dois pacientes com SCA e com indica&#231;&#227;o de interven&#231;&#227;o coron&#225;ria percut&#226;nea foram submetidos a dosagens de PCR de alta sensibilidade antes e 24 horas ap&#243;s a ICP. An&#225;lise por ultrassom HV da les&#227;o-alvo foi realizada antes da ICP. RESULTADOS: A m&#233;dia de idade foi de 55,3 &#177; 4,9 anos, sendo 76,9% homens, 67,3% hipertensos e 30,8% diab&#233;ticos. A &#225;rea luminal m&#237;nima foi de 3,9 &#177; 1,3 mm&#178;, e a carga de placa de 69 &#177; 11,3%. Os componentes da placa foram assim identificados: fibr&#243;tico (59,6 &#177; 15,8%), fibrolip&#237;dico (7,6 &#177; 8,2%), c&#225;lcio (12,1 &#177; 9,2%), necr&#243;tico (20,7 &#177; 12,7%). N&#227;o observamos correla&#231;&#227;o entre os n&#237;veis basais de PCR ou a varia&#231;&#227;o dentre os valores pr&#233; e p&#243;s-ICP com os componentes da placa. CONCLUS&#195;O: Neste estudo, a composi&#231;&#227;o das placas pela HV foi predominantemente fibr&#243;tica, com alto conte&#250;do necr&#243;tico. N&#227;o foi encontrada correla&#231;&#227;o entre a PCR e os componentes da les&#227;o culpada em pacientes com SCA.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>S&#237;ndrome Coronariana Aguda</kwd>
        <kwd>Placa Ateroscler&#243;tica</kwd>
        <kwd>Prote&#237;na C-Reativa</kwd>
        <kwd>T&#233;cnicas Histol&#243;gicas</kwd>
        <kwd>Diagn&#243;stico por Imagem</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>11</day>
        <month>06</month>
        <year>2013</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Correla&#231;&#227;o da composi&#231;&#227;o de placas &#224; histologia virtual com prote&#237;na C-reativa</bold>
    </p>
    <p>
      <bold>Dimytri Alexandre de Alvim Siqueira; Amanda Guerra Moraes R. Sousa; Jos&#233; de Ribamar Costa Junior; Ricardo Alves da Costa; Rodolfo Staico; Luis Fernando Leite Tanajura; Marinella Patrizia Centemero; Fausto Feres; Alexandre Antonio Cunha Abizaid; J. Eduardo Moraes R. Sousa</bold>
    </p>
    <p>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold> FUNDAMENTOS:</bold> Estudos pr&#233;vios demonstram que o principal determinante de vulnerabilidade da placa ateroscler&#243;tica &#233; a sua composi&#231;&#227;o. Recentemente, diversos m&#233;todos de imagens e marcadores laboratoriais t&#234;m sido investigados visando identificar les&#245;es vulner&#225;veis. O ultrassom com Histologia Virtual<sup>&#174;</sup> (HV) permite a diferencia&#231;&#227;o e quantifica&#231;&#227;o dos componentes da placa. Por sua vez, a prote&#237;na C-reativa (PCR) &#233; apontada como importante preditor de eventos adversos. A correla&#231;&#227;o entre este marcador e as caracter&#237;sticas da placa n&#227;o &#233; bem estabelecida. </p>
    <p><bold>OBJETIVOS:</bold> Avaliar a constitui&#231;&#227;o da les&#227;o culpada em pacientes com s&#237;ndrome coron&#225;ria aguda (SCA) - conforme caracterizada pela HV - e investigar a rela&#231;&#227;o dos componentes da placa com o marcador inflamat&#243;rio PCR. </p>
    <p><bold>M&#201;TODOS:</bold> Cinquenta e dois pacientes com SCA e com indica&#231;&#227;o de interven&#231;&#227;o coron&#225;ria percut&#226;nea foram submetidos a dosagens de PCR de alta sensibilidade antes e 24 horas ap&#243;s a ICP. An&#225;lise por ultrassom HV da les&#227;o-alvo foi realizada antes da ICP. </p>
    <p><bold>RESULTADOS:</bold> A m&#233;dia de idade foi de 55,3 &#177; 4,9 anos, sendo 76,9% homens, 67,3% hipertensos e 30,8% diab&#233;ticos. A &#225;rea luminal m&#237;nima foi de 3,9 &#177; 1,3 mm<sup>2</sup>, e a carga de placa de 69 &#177; 11,3%. Os componentes da placa foram assim identificados: fibr&#243;tico (59,6 &#177; 15,8%), fibrolip&#237;dico (7,6 &#177; 8,2%), c&#225;lcio (12,1 &#177; 9,2%), necr&#243;tico (20,7 &#177; 12,7%). N&#227;o observamos correla&#231;&#227;o entre os n&#237;veis basais de PCR ou a varia&#231;&#227;o dentre os valores pr&#233; e p&#243;s-ICP com os componentes da placa. </p>
    <p><bold>CONCLUS&#195;O:</bold> Neste estudo, a composi&#231;&#227;o das placas pela HV foi predominantemente fibr&#243;tica, com alto conte&#250;do necr&#243;tico. N&#227;o foi encontrada correla&#231;&#227;o entre a PCR e os componentes da les&#227;o culpada em pacientes com SCA.</p>
    <p><bold>Palavras-chave:</bold> S&#237;ndrome Coronariana Aguda, Placa Ateroscler&#243;tica, Prote&#237;na C-Reativa, T&#233;cnicas Histol&#243;gicas, Diagn&#243;stico por Imagem.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A s&#237;ndrome coron&#225;ria aguda abrange amplo espectro de apresenta&#231;&#245;es cl&#237;nicas e evolu&#231;&#227;o progn&#243;stica, estando relacionada na maior parte dos casos a um mesmo substrato fisiopatol&#243;gico: a rotura ou a eros&#227;o de uma placa vulner&#225;vel<sup>1,2</sup>. Estudos histopatol&#243;gicos pr&#233;vios demonstram que o principal determinante de vulnerabilidade da placa ateroscler&#243;tica &#233; a sua composi&#231;&#227;o. Desta forma, les&#245;es caracterizadas por um grande n&#250;cleo lip&#237;dico, pela presen&#231;a de c&#233;lulas inflamat&#243;rias - em detrimento de c&#233;lulas musculares lisas e tecido fibroso - e por uma capa fibrosa fina estariam mais sujeitas &#224; instabiliza&#231;&#227;o<sup>3,4</sup>. </p>
    <p>Postula-se que a detec&#231;&#227;o precoce de fibroateromas de capa fina teria profundo impacto cl&#237;nico na preven&#231;&#227;o de eventos card&#237;acos adversos. Nos &#250;ltimos anos, diversos m&#233;todos de imagens cardiovasculares e marcadores laboratoriais t&#234;m sido investigados com este prop&#243;sito<sup>5,6</sup>. O ultrassom intracoron&#225;rio com radiofrequ&#234;ncia, tamb&#233;m denominado Histologia Virtual<sup>&#174;</sup> (Volcano Therapeutics, EUA), complementa as informa&#231;&#245;es anat&#244;micas providas pelo ultrassom intracoron&#225;rio convencional em escala de cinzas, permitindo n&#227;o s&#243; a avalia&#231;&#227;o das dimens&#245;es da placa, mas ainda uma pormenorizada caracteriza&#231;&#227;o tecidual da les&#227;o ateroscler&#243;tica<sup>7-9</sup>.</p>
    <p>Quatro componentes b&#225;sicos da placa (tecidos fibrolip&#237;dico e fibroso, c&#225;lcio, &#225;reas de atividade inflamat&#243;ria e necrose) s&#227;o determinados por esse m&#233;todo. Na reconstru&#231;&#227;o das imagens (<xref ref-type="fig" rid="aop5278fig01">Figura 1</xref>), tais elementos s&#227;o caracterizados por diferentes cores: verde claro (tecido fibrolip&#237;dico), verde escuro (tecido fibr&#243;tico), branco (c&#225;lcio) e vermelho (n&#250;cleo necr&#243;tico), que podem ainda ser quantificados em rela&#231;&#227;o &#224;s suas &#225;reas correspondentes ou ao porcentual ocupado por cada componente do volume total da placa<sup>10</sup>. Dentre os m&#233;todos laboratoriais investigados, a prote&#237;na C-reativa (PCR) &#233; um reagente de fase aguda e sens&#237;vel marcador de estado inflamat&#243;rio sist&#234;mico, sendo apontada como um importante preditor de eventos card&#237;acos adversos<sup>11,12</sup>. Contudo, a sua correla&#231;&#227;o com as caracter&#237;sticas da placa de ateroma n&#227;o &#233; bem estabelecida.</p>
    <p content-type="asset">
      <fig id="aop5278fig01">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf01.jpg"/></fig>
    </p>
    <p>O presente estudo tem como objetivos avaliar a constitui&#231;&#227;o da les&#227;o ateroscler&#243;tica culpada em pacientes com s&#237;ndrome coron&#225;ria aguda - conforme caracterizada pelo ultrassom com radiofrequ&#234;ncia - e investigar a rela&#231;&#227;o dos componentes da placa com o marcador inflamat&#243;rio prote&#237;na C-reativa.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Estudo prospectivo, constitu&#237;do por 52 pacientes consecutivos com s&#237;ndrome coron&#225;ria aguda com ou sem supradesnivelamento do segmento ST, admitidos no Instituto Dante Pazzanese de Cardiologia, no per&#237;odo de setembro de 2008 a novembro de 2009, tendo sido submetidos &#224; cinecoronariografia conforme indica&#231;&#227;o cl&#237;nica e candidatos &#224; interven&#231;&#227;o percut&#226;nea. A pesquisa foi aprovada pela Comiss&#227;o de &#201;tica em Pesquisa da Institui&#231;&#227;o, estando de acordo com a declara&#231;&#227;o de Helsinki. Todos os pacientes assinaram termo de consentimento livre e esclarecido.</p>
    <p>Constitu&#237;am crit&#233;rios de inclus&#227;o: idade igual ou superior a 18 anos; quadro cl&#237;nico de s&#237;ndrome coron&#225;ria aguda, ocorrido at&#233; 30 dias antes da realiza&#231;&#227;o da interven&#231;&#227;o percut&#226;nea; les&#227;o coron&#225;ria prim&#225;ria caracterizada por: a) obstru&#231;&#227;o <underline>&gt;</underline> 50 % da luz vascular pela avalia&#231;&#227;o visual, com extens&#227;o &lt; 18 mm e localiza&#231;&#227;o em vasos maiores que 2,5 mm, sendo considerada a les&#227;o respons&#225;vel ("culpada") pelo quadro cl&#237;nico apresentado. Foram exclu&#237;dos os pacientes com IAM a menos de 72 h de evolu&#231;&#227;o, com angina refrat&#225;ria, inst&#225;veis hemodinamicamente ou com fluxo coron&#225;rio TIMI (<italic>Trombolysis in Myocardial Infarction</italic>) &lt; 3 - que exigissem interven&#231;&#227;o coron&#225;ria imediata -, e portadores de les&#245;es obstrutivas (<underline>&gt;</underline> 50%) no tronco da coron&#225;ria esquerda, com oclus&#245;es totais e com les&#245;es com trombo no s&#237;tio da interven&#231;&#227;o (conforme demonstrado pela angiografia). Pacientes em vig&#234;ncia de infec&#231;&#227;o, portadores de patologias do tecido conjuntivo ou outras doen&#231;as inflamat&#243;rias cr&#244;nicas ou ainda em uso de corticosteroides foram tamb&#233;m exclu&#237;dos, uma vez que tais condi&#231;&#245;es poderiam influenciar nos resultados laboratoriais de dosagem da prote&#237;na C-reativa.</p>
    <p>
      <bold>Protocolo de aquisi&#231;&#227;o das imagens com ultrassom intracoron&#225;rio com radiofrequ&#234;ncia</bold>
    </p>
    <p>Ap&#243;s a cateteriza&#231;&#227;o do vaso culpado e antes da interven&#231;&#227;o coron&#225;ria, procedeu-se ao posicionamento de guia met&#225;lico 0,014" distalmente &#224; les&#227;o a ser tratada. O cateter de ultrassom com radiofrequ&#234;ncia Eagle Eye<sup>&#174;</sup> (Volcano Therapeutics, EUA) foi avan&#231;ado sobre o guia met&#225;lico, e posicionado inicialmente em segmento livre de doen&#231;a ateroscler&#243;tica significativa; ap&#243;s a conex&#227;o a um console espec&#237;fico (InVision Gold<sup>&#174;</sup>, Volcano Corporation Inc., Rancho Cordova, EUA), realizou-se a calibra&#231;&#227;o das imagens. O cateter de ultrassom foi ent&#227;o posicionado em segmento distal &#224; les&#227;o culpada, e, com o aux&#237;lio de dispositivo autom&#225;tico (R-100<sup>&#174;</sup>, Volcano Corporation Inc., Rancho Cordova, EUA), foi tracionado &#224; velocidade de 0,5 mm / segundo para a realiza&#231;&#227;o das sequ&#234;ncias das imagens.</p>
    <p>Ao t&#233;rmino da realiza&#231;&#227;o do ultrassom com radiofrequ&#234;ncia, seguiu-se o tratamento percut&#226;neo da les&#227;o culpada. De import&#226;ncia, a pr&#233;-dilata&#231;&#227;o da les&#227;o foi realizada somente ap&#243;s a obten&#231;&#227;o das imagens de ultrassom com Histologia Virtual<sup>&#174;</sup>, a fim de que as caracter&#237;sticas da placa refletissem seu estado natural, antes de qualquer interven&#231;&#227;o mec&#226;nica.</p>
    <p>A an&#225;lise das imagens da Histologia Virtual<sup>&#174;</sup> foi realizada por meio de programa espec&#237;fico (pcVH 2.2<sup>&#174;</sup>, Volcano Corporation Inc.<sup>&#174;</sup>, Rancho Cordova, EUA). Tal programa permite o contorno da membrana el&#225;stica externa e do l&#250;men, fornecendo, de forma autom&#225;tica, a classifica&#231;&#227;o dos quatro componentes da placa presentes na regi&#227;o de interesse (tecido fibroso, fibrolip&#237;dico, c&#225;lcio e n&#250;cleo necr&#243;tico). A an&#225;lise pelo ultrassom com radiofrequ&#234;ncia foi delimitada a um segmento de 10 mm da les&#227;o ateroscler&#243;tica a ser tratada. Tal segmento deveria abranger o ponto de maior obstru&#231;&#227;o do l&#250;men: assim, tomando-se a &#225;rea m&#237;nima da luz como refer&#234;ncia, eram determinados os 5 mm proximais e distais &#224; mesma. Baseado ainda na composi&#231;&#227;o porcentual da placa e na localiza&#231;&#227;o dos conte&#250;dos necr&#243;tico e de c&#225;lcio em rela&#231;&#227;o &#224; luz vascular, procedeu-se &#224; seguinte classifica&#231;&#227;o das les&#245;es pela Histologia Virtual<sup>&#174;</sup>:</p>
    <p>&#149; placa fibr&#243;tica: tecido fibr&#243;tico predominante, sem &#225;reas confluentes de tecido necr&#243;tico ou de c&#225;lcio; </p>
    <p>&#149; fibroateroma calcificado: presen&#231;a de &#225;reas confluentes de c&#225;lcio (&gt; 10% do porcentual de &#225;rea da placa) em tr&#234;s ou mais cortes consecutivos;</p>
    <p>&#149; fibroateroma: presen&#231;a de &#225;reas confluentes de tecido necr&#243;tico (&gt; 10% do porcentual de &#225;rea da placa) em tr&#234;s ou mais cortes consecutivos;</p>
    <p>&#149; fibroateroma de capa fina (FACF): presen&#231;a de &#225;reas confluentes de tecido necr&#243;tico (&gt; 10% do porcentual de &#225;rea da placa) em tr&#234;s ou mais cortes consecutivos e em direto contato com o l&#250;men (<xref ref-type="fig" rid="aop5278fig02">Figura 2</xref>).</p>
    <p content-type="asset">
      <fig id="aop5278fig02">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf02.jpg"/></fig>
    </p>
    <p>
      <bold>Coleta de amostras e dosagem de prote&#237;na C-reativa</bold>
    </p>
    <p>Antes da interven&#231;&#227;o coron&#225;ria, todos os pacientes foram submetidos &#224; avalia&#231;&#227;o cl&#237;nica, eletrocardiogr&#225;fica e laboratorial. As amostras de sangue perif&#233;rico para dosagens do marcador inflamat&#243;rio prote&#237;na C-reativa de alta sensibilidade pr&#233;-interven&#231;&#227;o foram obtidas do acesso arterial (por meio dos introdutores femoral ou radial), no momento anterior ao procedimento de revasculariza&#231;&#227;o percut&#226;nea. As amostras para as dosagens p&#243;s-procedimento foram obtidas 24 horas ap&#243;s a interven&#231;&#227;o. A an&#225;lise sorol&#243;gica com a dosagem de prote&#237;na C-reativa de alta sensibilidade foi realizada por teste de quimioluminesc&#234;ncia automatizado IMMULITE<sup>&#174;</sup> (DPCMedLab<sup>&#174;</sup>, Brasil). A varia&#231;&#227;o entre o n&#237;vel basal deste marcador inflamat&#243;rio e o observado 24 horas ap&#243;s a interven&#231;&#227;o foi definida como &#916; (delta) de PCR, sendo calculada em cada paciente.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>As vari&#225;veis categ&#243;ricas foram expressas em n&#250;meros absolutos e porcentagens, e apresentadas em tabelas de frequ&#234;ncia absoluta e relativa. A an&#225;lise de diferen&#231;as entre as vari&#225;veis categ&#243;ricas foi realizada com o teste do qui-quadrado de Pearson ou com teste exato de Fisher, quando necess&#225;rio. As vari&#225;veis cont&#237;nuas foram expressas como m&#233;dia e desvio-padr&#227;o. Diferen&#231;as entre as vari&#225;veis cont&#237;nuas foram determinadas pelo teste t de Student. Nas situa&#231;&#245;es nas quais a normalidade foi rejeitada, aplicou-se a compara&#231;&#227;o das vari&#225;veis por meio do teste n&#227;o param&#233;trico de Mann-Whitney. As correla&#231;&#245;es entre as vari&#225;veis quantitativas eram apresentadas segundo o coeficiente de correla&#231;&#227;o de Person. Para todos os testes, foi considerado um n&#237;vel de signific&#226;ncia de 5% (&#945; = 0,05). O programa PAWS Statistics (SPSS)<sup>&#174;</sup> (SPSS Inc, EUA) foi empregado para a an&#225;lise estat&#237;stica.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Caracter&#237;sticas cl&#237;nicas e angiogr&#225;ficas</bold>
    </p>
    <p>A m&#233;dia de idade dos pacientes foi de 55,3 &#177; 4,9 anos, sendo 76,9% do sexo masculino, 67,3% hipertensos, 30,8% diab&#233;ticos e 50% tabagistas. O quadro cl&#237;nico predominante que motivou a interven&#231;&#227;o coron&#225;ria percut&#226;nea foi o IAM com supra de ST, em sua fase mais tardia (interven&#231;&#227;o eletiva p&#243;s-IAM). Na <xref ref-type="table" rid="aop5278tab01">Tabela 1</xref>, encontram-se discriminadas as caracter&#237;sticas cl&#237;nicas gerais dos pacientes selecionados.</p>
    <p content-type="asset">
      <table-wrap id="aop5278tab01">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt01.jpg"/></table-wrap>
    </p>
    <p>Todos os pacientes foram medicados com aspirina 100-200 mg/dia; clopidogrel em <italic>bolus</italic> de 300-600 mg e manuten&#231;&#227;o de 75 mg/dia; e enoxaparina em dose plena (1 mg/kg 2x/dia), por pelo menos 24 horas antes da interven&#231;&#227;o coron&#225;ria.</p>
    <p>As caracter&#237;sticas angiogr&#225;ficas dos pacientes inclu&#237;dos s&#227;o mostradas na <xref ref-type="table" rid="aop5278tab02">Tabela 2</xref>. A maioria apresentava obstru&#231;&#227;o coron&#225;ria uniarterial, e a art&#233;ria mais frequentemente tratada foi a descendente anterior. Em rela&#231;&#227;o &#224; complexidade anat&#244;mica, 57,7% das les&#245;es foram classificadas como do tipo B2 ou C pela classifica&#231;&#227;o do ACC/AHA. A fun&#231;&#227;o ventricular esquerda, avaliada pela fra&#231;&#227;o de eje&#231;&#227;o global, foi de 57,8 &#177; 5,3%.</p>
    <p content-type="asset">
      <table-wrap id="aop5278tab02">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt02.jpg"/></table-wrap>
    </p>
    <p>A m&#233;dia do per&#237;odo decorrido entre a apresenta&#231;&#227;o cl&#237;nica inicial da s&#237;ndrome coron&#225;ria aguda e a realiza&#231;&#227;o da cinecoronariografia foi de 6,1 &#177; 1,8 dias, e de 8,2 &#177; 2,5 dias para a interven&#231;&#227;o coron&#225;ria percut&#226;nea. Em rela&#231;&#227;o &#224;s caracter&#237;sticas t&#233;cnicas do procedimento, 38% das les&#245;es foram pr&#233;-dilatadas previamente ao implante de <italic>stents</italic>. A p&#243;s-dilata&#231;&#227;o dos <italic>stents</italic> foi realizada em 90% dos pacientes.</p>
    <p>
      <bold>Resultados hospitalares e aos 30 dias</bold>
    </p>
    <p>Todos os 52 pacientes inclu&#237;dos foram submetidos &#224; interven&#231;&#227;o coron&#225;ria com sucesso cl&#237;nico e angiogr&#225;fico, recebendo alta hospitalar ap&#243;s per&#237;odo m&#233;dio de 1,32 &#177; 0,86 dias. Ao completarem trinta dias de evolu&#231;&#227;o p&#243;s-procedimento, os pacientes foram submetidos &#224;s avalia&#231;&#245;es cl&#237;nica, laboratorial e eletrocardiogr&#225;ficas planejadas. N&#227;o ocorreram casos de trombose de <italic>stent</italic>, eventos card&#237;acos maiores (&#243;bito, infarto ou acidente vascular cerebral) ou mesmo recidiva dos sintomas de isquemia mioc&#225;rdica neste per&#237;odo.</p>
    <p>
      <bold>Avalia&#231;&#227;o pelo ultrassom com Histologia Virtual<sup>&#174;</sup></bold>
    </p>
    <p>Os resultados do ultrassom com radiofrequ&#234;ncia (Histologia Virtual<sup>&#174;</sup>) est&#227;o na <xref ref-type="table" rid="aop5278tab03">Tabela 3</xref>. Conforme a classifica&#231;&#227;o proposta, predominaram as les&#245;es do tipo fibroateroma e fibroateroma calcificado (61,5% do total). Nove (17,3%) les&#245;es foram definidas com fibroateromas de capa fina.</p>
    <p content-type="asset">
      <table-wrap id="aop5278tab03">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt03.jpg"/></table-wrap>
    </p>
    <p>Em rela&#231;&#227;o &#224; m&#233;dia dos porcentuais dos componentes das placas, o tecido fibr&#243;tico foi o componente predominante (59,6 &#177; 15,8% do volume total das placas analisadas); cerca de 20% do volume total das les&#245;es era composto por n&#250;cleo necr&#243;tico. Na <xref ref-type="fig" rid="aop5278fig03">Figura 3</xref>, est&#227;o representados a mediana e os intervalos interquartis do porcentual volum&#233;trico de cada um dos quatro componentes da placa ateroscler&#243;tica.</p>
    <p content-type="asset">
      <fig id="aop5278fig03">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf03.jpg"/></fig>
    </p>
    <p>
      <bold>Associa&#231;&#227;o entre as caracter&#237;sticas da les&#227;o ateroscler&#243;tica &#224; Histologia Virtual<sup>&#174;</sup> com os n&#237;veis da prote&#237;na C-reativa</bold>
    </p>
    <p>O valor basal da prote&#237;na C-reativa nos pacientes inclu&#237;dos neste estudo foi de 16,02 &#177; 18,07 mg/l (valor de refer&#234;ncia &lt; 5 mg/l). N&#227;o foi observada associa&#231;&#227;o entre os porcentuais dos componentes da les&#227;o ateroscler&#243;tica, conforme os achados da Histologia Virtual<sup>&#174;</sup>, e o marcador inflamat&#243;rio prote&#237;na C-reativa de alta sensibilidade, dosado antes da interven&#231;&#227;o coron&#225;ria percut&#226;nea. Na <xref ref-type="fig" rid="aop5278fig04">Figura 4</xref>, encontram-se os gr&#225;ficos de correla&#231;&#227;o entre os diferentes componentes da placa e os n&#237;veis da prote&#237;na C-reativa pr&#233;-procedimento.</p>
    <p content-type="asset">
      <fig id="aop5278fig04">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf04.jpg"/></fig>
    </p>
    <p>A varia&#231;&#227;o m&#233;dia entre o n&#237;vel basal deste marcador inflamat&#243;rio e o observado 24 horas ap&#243;s a interven&#231;&#227;o [&#916; de PCR] foi de 3,18 &#177; 6,26 mg/L. Da mesma forma que a dosagem pr&#233;-interven&#231;&#227;o, n&#227;o foi detectada correla&#231;&#227;o entre as varia&#231;&#245;es individuais da prote&#237;na C reativa e os componentes das placas tratadas (<xref ref-type="fig" rid="aop5278fig05">Figura 5</xref>).</p>
    <p content-type="asset">
      <fig id="aop5278fig05">
        <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf05.jpg"/></fig>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Em nosso estudo prospectivo com pacientes com s&#237;ndrome coron&#225;ria aguda, a composi&#231;&#227;o das placas conforme o ultrassom com Histologia Virtual<sup>&#174;</sup> foi predominantemente fibr&#243;tica, com alto percentual de componente necr&#243;tico. N&#227;o foi encontrada correla&#231;&#227;o entre os n&#237;veis basais do marcador inflamat&#243;rio prote&#237;na C-reativa, ou mesmo entre a varia&#231;&#227;o de seus n&#237;veis pr&#233; e p&#243;s-interven&#231;&#227;o, e a composi&#231;&#227;o da placa ateroscler&#243;tica culpada nesta casu&#237;stica.</p>
    <p>Estudos patol&#243;gicos demonstram que a rotura de placa com grande n&#250;cleo inflamat&#243;rio e necr&#243;tico e a trombose subsequente s&#227;o os principais mecanismos que determinam a ocorr&#234;ncia da s&#237;ndrome coron&#225;ria aguda. Tais achados t&#234;m encontrado correspond&#234;ncia com os resultados da Histologia Virtual<sup>&#174;</sup>. Utilizando o m&#233;todo, Pundziute e cols.<sup>13</sup> observaram que a m&#233;dia dos porcentuais do n&#250;cleo necr&#243;tico das les&#245;es coron&#225;rias observadas era significativamente maior em portadores de s&#237;ndrome coron&#225;ria aguda do que em pacientes com angina est&#225;vel (11,2 &#177; 6,1% <italic>versus</italic> 9,1 &#177; 4,6%, p = 0,02). Em an&#225;lise com 318 casos, Hong e cols.<sup>14</sup> relatam que a morfologia das placas culpadas de pacientes com quadro inst&#225;vel &#233; distinta das les&#245;es-alvo de pacientes est&#225;veis: o n&#250;cleo necr&#243;tico no ponto de maior redu&#231;&#227;o luminal &#233; maior (33% <italic>versus</italic> 29%, p = 0,015) e o porcentual de tecido fibrolip&#237;dico &#233; menor (5% <italic>versus</italic> 7%, p = 0,020), respectivamente. Rodriguez-Granillo e cols.<sup>15</sup> demonstraram maior m&#233;dia porcentual de conte&#250;do necr&#243;tico nas les&#245;es n&#227;o culpadas de pacientes com s&#237;ndrome inst&#225;vel do que nas placas ateroscler&#243;ticas de pacientes est&#225;veis (12,26% &#177; 7,0% <italic>versus</italic> 7,4 &#177; 5,5%), p &lt; 0,006), sugerindo que estado pr&#243;-inflamat&#243;rio sist&#234;mico possa influenciar n&#227;o s&#243; a instabiliza&#231;&#227;o das les&#245;es culpadas, mas tamb&#233;m a ativa&#231;&#227;o de les&#245;es quiescentes em outros s&#237;tios coron&#225;rios. Surmely e cols.<sup>16</sup> relatam que, ao menos no local com menor di&#226;metro luminal, a &#225;rea do componente fibr&#243;tico pode ser maior nas placas de pacientes com s&#237;ndrome aguda do que em indiv&#237;duos est&#225;veis (6,0 &#177; 10,7 <italic>versus</italic> 61,4 &#177; 8,9%, p = 0,034). Em nosso estudo, a maior parte das les&#245;es culpadas foram classificadas como fibroateromas ou fibroateromas calcificados; grande varia&#231;&#227;o de tipos de placa foi observada, sendo 17,3% definidas com fibroateromas de capa fina. Houve predom&#237;nio do componente fibr&#243;tico (59,6% &#177; 15,8%) e grande porcentual de n&#250;cleo necr&#243;tico (20,7% &#177; 12,7%) nas les&#245;es analisadas.</p>
    <p>Marcador laboratorial de estado inflamat&#243;rio sist&#234;mico, a prote&#237;na C-reativa &#233; tamb&#233;m sintetizada no local da placa ateroscler&#243;tica e refletiria o processo de instabiliza&#231;&#227;o<sup>7,8</sup>. Diversos estudos procuraram avaliar a associa&#231;&#227;o entre os n&#237;veis de prote&#237;na C-reativa com as caracter&#237;sticas das placas ateroscler&#243;ticas ao ultrassom intracoron&#225;rio monocrom&#225;tico. Em estudo com pacientes p&#243;s-IAM, Sano e cols.<sup>17</sup> encontraram maior preval&#234;ncia de les&#245;es com achados ultrassonogr&#225;ficos de rotura, de remodelamento positivo ou com lagos lip&#237;dicos nos indiv&#237;duos que apresentavam n&#237;veis elevados de prote&#237;na C-reativa, quando comparados a pacientes com n&#237;veis normais deste marcador. Hong e cols.<sup>18</sup>, por sua vez, em estudo com ultrassom intracoron&#225;rio realizado nos tr&#234;s vasos principais, encontraram que n&#237;veis elevados de prote&#237;na C-reativa foram os &#250;nicos preditores de placas com rotura. Em nossa investiga&#231;&#227;o com o ultrassom intracoron&#225;rio com radiofrequ&#234;ncia, contudo, n&#227;o foi demonstrada associa&#231;&#227;o dos porcentuais de componentes da placa culpada com os n&#237;veis s&#233;ricos de prote&#237;na C-reativa. &#201; poss&#237;vel que, ao analisarmos apenas as les&#245;es que j&#225; tenham sofrido eros&#227;o ou rotura, parte do n&#250;cleo necr&#243;tico j&#225; tenha sido embolizada; por conseguinte, a observa&#231;&#227;o de um menor porcentual deste componente pode ter resultado na classifica&#231;&#227;o de determinadas les&#245;es como fibr&#243;ticas e influenciado na correla&#231;&#227;o com os n&#237;veis de prote&#237;na C-reativa.</p>
    <p>Sabe-se que a emboliza&#231;&#227;o distal de conte&#250;do necr&#243;tico e de <italic>debris</italic> da placa ateroscler&#243;tica, ocorrida durante a interven&#231;&#227;o coron&#225;ria percut&#226;nea, associa-se a desfechos cl&#237;nicos e angiogr&#225;ficos adversos. Neste cen&#225;rio, tem-se investigado a utilidade da Histologia Virtual<sup>&#174;</sup> em identificar les&#245;es com maior risco de complica&#231;&#245;es. Diversos estudos com pacientes com IAM com supra de ST demonstram que um maior porcentual do n&#250;cleo necr&#243;tico nas placas tratadas associa-se ao surgimento de sinais eletrocardiogr&#225;ficos sugestivos de n&#227;o reperfus&#227;o<sup>19</sup>, &#224; ocorr&#234;ncia de <italic>no-reflow</italic><sup>20</sup> e ao aparecimento de sinais transit&#243;rios e de alta frequ&#234;ncia ao Doppler intracoron&#225;rio<sup>21</sup> - indicativos de emboliza&#231;&#227;o distal. Tais complica&#231;&#245;es podem acompanhar-se de aumento dos n&#237;veis de prote&#237;na C-reativa. Em nossa casu&#237;stica, n&#227;o ocorreram complica&#231;&#245;es isqu&#234;micas relacionadas ao procedimento de revasculariza&#231;&#227;o, n&#227;o sendo tamb&#233;m detectada qualquer associa&#231;&#227;o entre os porcentuais dos componentes da les&#227;o culpada com a magnitude de eleva&#231;&#227;o de prote&#237;na C-reativa. O tratamento farmacol&#243;gico institu&#237;do antes da interven&#231;&#227;o (dupla terapia antiplaquet&#225;ria, antitromb&#237;nicos e estatinas) pode explicar a discord&#226;ncia entre os achados de nosso estudo e aqueles previamente relatados.</p>
    <p>
      <bold>Limita&#231;&#245;es</bold>
    </p>
    <p>Algumas das limita&#231;&#245;es deste estudo dizem respeito ao pr&#243;prio m&#233;todo de imagem utilizado. Primeiramente, por tratar-se de tecnologia baseada nos princ&#237;pios do ultrassom, a Histologia Virtual<sup>&#174;</sup> apresenta resolu&#231;&#227;o axial de 100 &#181;m e resolu&#231;&#227;o lateral de 250 &#181;m, o que impede a detec&#231;&#227;o de placas com capa fibr&#243;tica ainda mais fina (&lt; 65 &#181;m), apontadas como precursoras de eventos isqu&#234;micos agudos. Ademais, nem todos os componentes da placa s&#227;o identificados pelo m&#233;todo: a presen&#231;a de trombo intraluminal, por exemplo, n&#227;o &#233; contemplada pelos algoritmos de classifica&#231;&#227;o contempor&#226;neos. Assim, o tecido tromb&#243;tico &#233; classificado automaticamente como componente fibr&#243;tico ou fibrolip&#237;dico<sup>12</sup>. Por este motivo, a observa&#231;&#227;o de imagens sugestivas de trombo &#224; angiografia (comuns nos pacientes com s&#237;ndromes agudas) constitui um dos crit&#233;rios de exclus&#227;o de nosso estudo. De forma similar ao ultrassom intracoron&#225;rio convencional, a deposi&#231;&#227;o n&#227;o confluente de c&#225;lcio n&#227;o acarreta dificuldades na avalia&#231;&#227;o de tecidos mais profundos da placa. Por outro lado, devido ao surgimento de sombra ac&#250;stica, a sua disposi&#231;&#227;o confluente e organizada pode reduzir a acur&#225;cia do m&#233;todo em reconhecer outros componentes.</p>
    <p>Naturalmente, os achados desta investiga&#231;&#227;o n&#227;o eliminam a potencial indica&#231;&#227;o deste m&#233;todo de imagem nas in&#250;meras outras possibilidades em que vem sendo estudado, dentre as quais se destacam: o melhor entendimento da evolu&#231;&#227;o natural da doen&#231;a coron&#225;ria<sup>22,23</sup>; os efeitos de terapias farmacol&#243;gicas que visam &#224; regress&#227;o ou estabiliza&#231;&#227;o de placas ateroscler&#243;ticas<sup>24-26</sup>; e a correla&#231;&#227;o entre o tipo e a composi&#231;&#227;o das les&#245;es com os resultados das interven&#231;&#245;es percut&#226;neas<sup>19-21,27</sup>.</p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>Em nosso estudo, a composi&#231;&#227;o das placas obtidas com o ultrassom com a Histologia Virtual<sup>&#174;</sup> foi predominantemente fibr&#243;tica e com grande conte&#250;do de n&#250;cleo necr&#243;tico. N&#227;o foi observada correspond&#234;ncia entre os n&#237;veis basais do marcador inflamat&#243;rio prote&#237;na C-reativa - ou mesmo entre a varia&#231;&#227;o de seus n&#237;veis pr&#233; e p&#243;s-interven&#231;&#227;o - com a composi&#231;&#227;o da placa ateroscler&#243;tica culpada em pacientes com s&#237;ndrome coron&#225;ria aguda.</p>
    <p>
      <bold>Contribui&#231;&#227;o dos autores</bold>
    </p>
    <p>Concep&#231;&#227;o e desenho da pesquisa e An&#225;lise estat&#237;stica: Siqueira DAA, Costa Junior JR; Obten&#231;&#227;o de dados: Siqueira DAA, Costa Junior JR, Costa RA, Staico R, Tanajura LFL, Centemero MP, Feres F, Abizaid AAC; An&#225;lise e interpreta&#231;&#227;o dos dados: Siqueira DAA, Sousa AGMR, Costa Junior JR; Obten&#231;&#227;o de financiamento: Siqueira DAA, Sousa AGMR, Abizaid AAC; Reda&#231;&#227;o do manuscrito: Siqueira DAA; Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual: Siqueira DAA, Sousa AGMR, Costa RA, Staico R, Tanajura LFL, Abizaid AAC, Sousa JEMR.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi parcialmente financiado pela CAPES.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de doutorado de Dimytri Alexandre de Alvim Siqueira pelo Instituto Dante Pazzanese de Cardiologia, entidade associada da Universidade de S&#227;o Paulo - USP</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Dimytri Alexandre de Alvim Siqueira </p>
        <p> Rua Maestro Callia, 271 Apto. 114, Vila Mariana </p>
        <p> CEP 04012-100, S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="dimytri@cardiol.br">dimytri@cardiol.br</email>, </p>
        <p>
          <email xlink:href="dimytrisiqueira@gmail.com">dimytrisiqueira@gmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 19/11/12; revisado em 10/12/12; aceito em 14/02/13.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83(3):361-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The pathophysiology of acute coronary syndromes</article-title>
          <source>Heart</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>361</fpage>
          <lpage>6</lpage>
          <issue>3</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Current concepts of the pathogenesis of the acute coronary syndromes</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>365</fpage>
          <lpage>72</lpage>
          <issue>3</issue>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary plaque disruption</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>657</fpage>
          <lpage>71</lpage>
          <issue>3</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Falk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Fuster</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15(6):439-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vulnerable plaque: the pathology of unstable coronary lesions</article-title>
          <source>J Interv Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>439</fpage>
          <lpage>46</lpage>
          <issue>6</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Virmani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Kolodgie</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Farb</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108(14):1664-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1664</fpage>
          <lpage>72</lpage>
          <issue>14</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Naghavi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Casscells</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Litovsky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rumberger</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Interv. 2009;2(5):482-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Advances in intravascular imaging</article-title>
          <source>Circ Cardiovasc Interv</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>482</fpage>
          <lpage>90</lpage>
          <issue>5</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maehara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002;106(17):2200-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary plaque classification with intravascular ultrasound radiofrequency data analysis</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2200</fpage>
          <lpage>6</lpage>
          <issue>17</issue>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nair</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kuban</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Tuzcu</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Schoenhagen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nissen</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Vince</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol. 2006;47(12):2405-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2405</fpage>
          <lpage>12</lpage>
          <issue>12</issue>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nasu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsuchikane</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Katoh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Vince</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Virmani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Surmely</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Garcia-Garcia HM, Gonzalo N, Regar E, Serruys PW. Virtual histology and optical coherence tomography: from research to a broad clinical application. Heart. 2009;95(16):1362-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Virtual histology and optical coherence tomography: from research to a broad clinical application</article-title>
          <source>Heart</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1362</fpage>
          <lpage>74</lpage>
          <issue>16</issue>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Garcia</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Gonzalo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Regar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Serruys</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Garc&#237;a-Garc&#237;a HM, Mintz GS, Lerman A, Vince DG, Margolis MP, Morel MA, et al. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention. 2009;5(2):177-89.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting</article-title>
          <source>EuroIntervention</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>177</fpage>
          <lpage>89</lpage>
          <issue>2</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Garc&#237;a-Garc&#237;a</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vince</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical application of C-reactive protein for cardiovascular disease detection and prevention</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>363</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ridker</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy AS, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105(15):1760-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1760</fpage>
          <lpage>3</lpage>
          <issue>15</issue>
          <volume>105</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sabatine</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>de Lemos</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Rifai</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Pundziute G, Schuijf JD, Jukema JW, Decramer I, Sarno G, Vanhoenacker PK, et al. Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J. 2008;29(19):2373-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2373</fpage>
          <lpage>81</lpage>
          <issue>19</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pundziute</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schuijf</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Jukema</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Decramer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sarno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vanhoenacker</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Hong MK, Mintz GS, Lee CW, Lee JW, Park JH, Park DW, et al. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. Am J Cardiol. 2008;101(5):568-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>568</fpage>
          <lpage>72</lpage>
          <issue>5</issue>
          <volume>101</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Rodriguez-Granillo GA, McFadden EP, Valgimigli M, van Mieghem CA, Regar E, de Feyter PJ, et al. Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation. Am Heart J. 2006;151(5):1020-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1020</fpage>
          <lpage>4</lpage>
          <issue>5</issue>
          <volume>151</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez-Granillo</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>McFadden</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Valgimigli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Mieghem</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Regar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>de Feyter</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Surmely JF, Nasu K, Fujita H, Terashima M, Matsubara T, Tsuchikane E, et al. Coronary plaque composition of culprit/target lesions according to the clinical presentation: a virtual histology intravascular ultrasound analysis. Eur Heart J. 2006;27(24):2939-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary plaque composition of culprit/target lesions according to the clinical presentation: a virtual histology intravascular ultrasound analysis</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2939</fpage>
          <lpage>44</lpage>
          <issue>24</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Surmely</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Nasu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Terashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsuchikane</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Sano T, Tanaka A, Namba M. C-reactive protein and lesion morphologyin patients with acute myocardial infarction. Circulation. 2003;108(3):282-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>C-reactive protein and lesion morphologyin patients with acute myocardial infarction</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>282</fpage>
          <lpage>5</lpage>
          <issue>3</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Namba</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 2004;110(8):928-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>928</fpage>
          <lpage>33</lpage>
          <issue>8</issue>
          <volume>110</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Kawaguchi R, Oshima S, Jingu M, Tsurugaya H, Toyama T, Hoshizaki H, et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial Infarction. J Am Coll Cardiol. 2007;50(17):1641-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial Infarction</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1641</fpage>
          <lpage>6</lpage>
          <issue>17</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kawaguchi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oshima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jingu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsurugaya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Toyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hoshizaki</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Nakamura T, Kubo N, Ako J, Momomura S. Angiographic no-reflow phenomenon and plaque characteristics by virtual histology intravascular ultrasound in patients with acute myocardial infarction. J Interv Cardiol. 2007;20(5):335-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Angiographic no-reflow phenomenon and plaque characteristics by virtual histology intravascular ultrasound in patients with acute myocardial infarction</article-title>
          <source>J Interv Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>335</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ako</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Momomura</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Kawamoto T, Okura H, Koyama Y, Toda I, Taguchi H, Tamita K, et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol. 2007;50(17):1635-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1635</fpage>
          <lpage>40</lpage>
          <issue>17</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kawamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Koyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Taguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tamita</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al for the PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A prospective natural-history study of coronary atherosclerosis</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>226</fpage>
          <lpage>35</lpage>
          <issue>3</issue>
          <volume>364</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Maehara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lansky</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>de Bruyne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cristea</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1262</fpage>
          <lpage>75</lpage>
          <issue>5</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Virmani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kolodgie</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Farb</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, et al. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv. 2009;2(7):689-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound</article-title>
          <source>JACC Cardiovasc Interv</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>689</fpage>
          <lpage>96</lpage>
          <issue>7</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nasu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsuchikane</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Katoh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ehara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, et al. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. JACC Cardiovasc Interv. 2009;2(7):679-88.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis</article-title>
          <source>JACC Cardiovasc Interv</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>679</fpage>
          <lpage>88</lpage>
          <issue>7</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Samady H, McDaniel MC. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound? JACC Cardiovasc Interv. 2009;2(7):697-700.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound</article-title>
          <source>JACC Cardiovasc Interv</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>697</fpage>
          <lpage>700</lpage>
          <issue>7</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Samady</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McDaniel</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Sangiorgi GM, Clementi F, Cola C, Biondi-Zoccai G. Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "it's a long way to tipperary"? Catheter Cardiovasc Interv. 2007;70(2):203-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "it's a long way to tipperary"?</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>203</fpage>
          <lpage>10</lpage>
          <issue>2</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sangiorgi</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Clementi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cola</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Biondi-Zoccai</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Correlation between plaque composition as assessed by virtual histology and C-reactive protein</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Previous studies have shown that coronary plaque composition plays a pivotal role in plaque instability, and imaging modalities and serum biomarkers have been investigated to identify vulnerable plaque. Virtual histology IVUS (VH-IVUS) characterizes plaque components as calcified, fibrotic, fibrofatty, or necrotic core. C-reactive protein (hsCRP) is an independent risk factor and a powerful predictor of future coronary events. However, a relationship between inflammatory response indicated by CRP and plaque characteristics in ACS patients remains not well established. OBJECTIVE: To determine, by using VH-IVUS, the relation between coronary plaque components and plasma high-sensitivity CRP levels in patients with acute coronary syndromes (ACS). METHODS: 52 patients with ACS were enrolled in this prospective study. Electrocardiographically-gated VH-IVUS were performed in the culprit lesion before PCI. Blood sample was drawn from all patients before the procedure and after 24 hours, and hs-CRP levels were determined. RESULTS: Mean age was 55.3&#177;4.9 years, 76.9% were men and 30.9% had diabetes. Mean MLA was 3.9&#177;1.3 mm&#178;, and plaque burden was 69&#177;11.3%, as assessed by IVUS. VH-IVUS analysis at the minimum luminal site identified plaque components: fibrotic (59.6&#177;15.8%), fibrofatty (7.6&#177;8.2%), dense calcium (12.1&#177;9.2%) and necrotic core (20.7&#177;12.7%). Plasma hs-CRP (mean 16.02&#177;18.07 mg/L) did not correlate with necrotic core (r=-0.089, p = 0.53) and other plaque components. CONCLUSIONS: In this prospective study with patients with ACS, the predominant components of the culprit plaque were fibrotic and necrotic core. Serum hs C-reactive protein levels did not correlate with plaque composition.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Acute Coronary Syndrome</kwd>
        <kwd>Plaque, Atherosclerosis</kwd>
        <kwd>C-Reactive Protein</kwd>
        <kwd>Histological Techniques</kwd>
        <kwd>Diagnostic Imaging</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="enda-body2">
          <label>
            <bold>Correlation between plaque composition as assessed by virtual histology and C-reactive protein</bold>
          </label>
          <p>
            <bold>Dimytri Alexandre de Alvim Siqueira; Amanda Guerra Moraes R. Sousa; Jos&#233; de Ribamar Costa Junior; Ricardo Alves da Costa; Rodolfo Staico; Luis Fernando Leite Tanajura; Marinella Patrizia Centemero; Fausto Feres; Alexandre Antonio Cunha Abizaid; J. Eduardo Moraes R. Sousa</bold>
          </p>
        </fn>
      </p>
      <p>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Previous studies have shown that coronary plaque composition plays a pivotal role in plaque instability, and imaging modalities and serum biomarkers have been investigated to identify vulnerable plaque. Virtual histology IVUS (VH-IVUS) characterizes plaque components as calcified, fibrotic, fibrofatty, or necrotic core. C-reactive protein (hsCRP) is an independent risk factor and a powerful predictor of future coronary events. However, a relationship between inflammatory response indicated by CRP and plaque characteristics in ACS patients remains not well established.</p>
      <p><bold>OBJECTIVE:</bold> To determine, by using VH-IVUS, the relation between coronary plaque components and plasma high-sensitivity CRP levels in patients with acute coronary syndromes (ACS).</p>
      <p><bold>METHODS:</bold> 52 patients with ACS were enrolled in this prospective study. Electrocardiographically-gated VH-IVUS were performed in the culprit lesion before PCI. Blood sample was drawn from all patients before the procedure and after 24 hours, and hs-CRP levels were determined. </p>
      <p><bold>RESULTS:</bold> Mean age was 55.3&#177;4.9 years, 76.9% were men and 30.9% had diabetes. Mean MLA was 3.9&#177;1.3 mm2, and plaque burden was 69&#177;11.3%, as assessed by IVUS. VH-IVUS analysis at the minimum luminal site identified plaque components: fibrotic (59.6&#177;15.8%), fibrofatty (7.6&#177;8.2%), dense calcium (12.1&#177;9.2%) and necrotic core (20.7&#177;12.7%). Plasma hs-CRP (mean 16.02&#177;18.07 mg/L) did not correlate with necrotic core (r=-0.089, p = 0.53) and other plaque components.</p>
      <p><bold>CONCLUSIONS:</bold> In this prospective study with patients with ACS, the predominant components of the culprit plaque were fibrotic and necrotic core. Serum hs C-reactive protein levels did not correlate with plaque composition . </p>
      <p><bold>Keywords:</bold> Acute Coronary Syndrome; Plaque, Atherosclerosis; C-Reactive Protein; Histological Techniques; Diagnostic Imaging.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The term acute coronary syndrome encompasses a broad spectrum of clinical presentations and prognostic evolutions, and is related mostly to one pathophysiologic substrate: the rupture or erosion of a vulnerable plaque<sup>1,2</sup>. Previous studies demonstrate that the main determinant of the atherosclerotic plaque vulnerability is its composition. Thus, lesions characterized by a large lipid core, by the presence of inflammatory cells (instead of smooth muscle cells and fibrous tissue) and thin-cap fibrosis were more subjected to instabilization<sup>3,4</sup>.</p>
      <p>It is postulated that the early detection of thin-cap fibroatheromas would have a profound impact on the prevention of cardiac adverse events. Recently, various cardiovascular imaging methods and laboratorial markers have been investigated with this purpose<sup>5,6</sup>. Intracoronary ultrasound with radiofrequency, also known as Virtual Histology<sup>&#174;</sup> (Volcano Therapeutics, EUA), complements anatomic information provided by conventional intracoronary ultrasound, allowing not only the evaluation of plaque dimensions but detailed tissue characterization of the atherosclerotic lesion<sup>7-9</sup>.</p>
      <p>Four basic components of the plaque (fibrous and fibrofatty tissues, calcium and areas with inflammatory activity and necrosis) are determined by the method. In imaging reconstruction (<xref ref-type="fig" rid="en_aop5278fig01-body2">Figure 1</xref>), these elements are characterized by different colors: light green (fibrofatty tissue), dark green (fibrotic tissue), white (calcium) and red (necrotic core), which can also be quantified according to their corresponding areas or to the percentage of each component in the total plaque volume<sup>10</sup>. Among the laboratorial methods that were investigated, C-reactive protein (CRP) is an acute-phase reactant and a sensitive marker of the systemic inflammatory status, and is considered an important predictor of cardiac adverse events<sup>11,12</sup>. However, its correlation with atheroma plaque characteristics is not well established.</p>
      <p content-type="asset">
        <fig id="en_aop5278fig01-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf01-en.jpg"/></fig>
      </p>
      <p>The present study aims to evaluate the constitution of the culprit atherosclerotic lesion in patients with acute coronary syndrome (as characterized by radiofrequency ultrasound) and investigate the relationship of the plaque components and the inflammatory marker C-reactive protein.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This is a prospective study of 52 consecutive patients with acute coronary syndrome with or without ST segment elevation, admitted at the Dante Pazzanese Cardiology Institute from September 2008 to November 2009, submitted to cinecoronariography according to clinical indication and who were candidates to percutaneous intervention. The study was approved by the Ethics Committee of the Institution involved, in compliance with the Declaration of Helsinki. All patients signed an informed consent document.</p>
      <p>The inclusion criteria were: patients <underline>&gt;</underline>18 years old, whose clinical picture was compatible with acute coronary syndrome that had occurred up to 30 days before coronary percutaneous intervention; primary coronary lesion characterized by: a) obstruction <underline>&gt;</underline> 50 % of the vascular lumen according to visual evaluation, with an extension &lt;18 mm and localized in vessels &gt;2.5 mm, considered the responsible lesion ("culprit") for the clinical picture. Patient with AMI &lt; 72 h, refractory angina, hemodynamic instability or coronary flux TIMI (<italic>Thrombolysis in Myocardial Infarction</italic>) &lt; 3 requiring immediate coronary intervention and obstructive lesions (<underline>&gt;</underline> 50%) of the left coronary trunk, with total occlusions and thrombotic lesions at the intervention site (according to angiography) were excluded. Patients with current infections, connective tissue diseases or other chronic inflammatory conditions or using corticosteroids were also excluded, since these conditions could also influence the C-reactive protein laboratory results. </p>
      <p>Imaging protocol with intracoronary ultrasound with radiofrequency</p>
      <p>After characterizing the culprit vessel and before coronary intervention, a 0.014" metallic guide wire was positioned distally to the lesion to be treated. The Eagle Eye<sup>&#174;</sup>radiofrequency ultrasound probe (Volcano Therapeutics, EUA) was advanced over the metallic guide wire and positioned initially in a segment free of significant atherosclerotic disease; after connection to a specific console (InVision Gold<sup>&#174;</sup>, Volcano Corporation Inc., Rancho Cordova, EUA), the images were calibrated. The ultrasound probe was then positioned distally to the culprit lesion, and was pulled at the velocity of 0.5 mm/sec with an automatic device (R-100<sup>&#174;</sup>, Volcano Corporation Inc., Rancho Cordova, EUA) for obtaining image sequences. </p>
      <p>After completion of the radiofrequency ultrasound, culprit lesion percutaneous treatment followed. Of note, lesion pre-dilation was performed only after obtaining ultrasound images with Virtual Histology<sup>&#174;</sup>, so that the plaque characteristics reflected its natural status, before any mechanical intervention.</p>
      <p>Virtual Histology<sup>&#174;</sup> image analysis was performed by specific software (pcVH 2.2<sup>&#174;</sup>, Volcano Corporation Inc.<sup>&#174;</sup>, Rancho Cordova, EUA). This software allows that the lumen and the external elastic membrane are contoured, providing an automatic classification of the four plaque components in the interest region (fibrous and fibrofatty tissue, calcium and necrotic core). Radiofrequency ultrasound analysis was limited to a 10 mm-segment of the atherosclerotic lesion to be treated. This segment must encompass the major obstruction point of the lumen; thus, taking the minimum lumen area as reference, 5 mm were determined proximally and distally to it. Based on the percent composition of the plaque and the localization of the calcium and necrotic contents in relation to the vascular lumen, the lesions were classified by Virtual Histology<sup>&#174;</sup> as follows:</p>
      <p>&#149; fibrotic plaque: predominantly fibrotic tissue, with no confluent necrotic tissue areas or calcium;</p>
      <p>&#149; calcified fibroatheroma: presence of calcium confluent areas (&gt; 10% of the plaque area) in three or more consecutive slices;</p>
      <p>&#149; fibroatheroma: presence of necrotic tissue confluent areas (&gt; 10% of the plaque area) in three or more consecutive slices;</p>
      <p>&#149; thin-cap fibroatheroma (TCFA): presence of necrotic tissue confluent areas (&gt; 10% of the plaque area) in three or more consecutive slices and in direct contact with the vessel lumen (<xref ref-type="fig" rid="en_aop5278fig02-body2">Figure 2</xref>).</p>
      <p content-type="asset">
        <fig id="en_aop5278fig02-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf02-en.jpg"/></fig>
      </p>
      <p>
        <bold>Sample collection and C-reactive protein measurement</bold>
      </p>
      <p>Before coronary intervention, all patients were submitted to clinical, electrocardiographic and laboratorial evaluation. Peripheral blood samples for measuring high sensitivity C-reactive protein (an inflammatory marker) were obtained from the arterial access (by means of radial or femoral introducer sheath) immediately before the percutaneous revascularization procedure. The post-procedure samples were obtained 24 hours after the intervention. The serum high sensitivity C-reactive protein measurement was measured with the automatized chemoluminescence test IMMULITE<sup>&#174;</sup> (DPCMedLab<sup>&#174;</sup>, Brazil). The variation between this inflammatory marker's basal levels and the one observed 24 hours after the intervention was defined as &#916; (delta) CRP, and was calculated for each patient.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>The categorical variables were expressed in absolute figures and percentages, and presented as relative and absolute frequency tables. The analysis of the differences among the categorical variables was performed by the Pearson's chi-square test and the Fisher exact test, when necessary. The continuous variables were expressed as mean and standard deviation. The differences among continuous variables were determined by the Student t test. When normality was rejected, the variables were compared by the Mann-Whitney non-parametric test. The correlations among the quantitative variables were presented according to the Pearson correlation coefficient. A 5% significance level was considered for all tests (&#945; = 0.05). The software PAWS Statistics (SPSS)<sup>&#174;</sup> (SPSS Inc, EUA) was employed in the statistical analysis.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Angiographic and clinical characteristics</bold>
      </p>
      <p>Mean age was 55.3 &#177; 4.9 years; 76.9% were male, 67.3% had arterial hypertension, 30.8% were diabetic and 50% were smokers. The predominant clinical picture that motivated the percutaneous coronary intervention was ST segment elevation acute myocardial infarction in its later phase (post-AMI elective intervention). The general clinical characteristics of the selected patients are discriminated on <xref ref-type="table" rid="en_aop5278tab01-body2">Table 1</xref>.</p>
      <p content-type="asset">
        <table-wrap id="en_aop5278tab01-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt01-en.jpg"/></table-wrap>
      </p>
      <p>All patients were treated with aspirin (100-200 mg/d); clopidogrel (300-600 mg bolus and 75 mg/d for maintenance); and full-dose enoxaparin (1 mg/kg twice daily) for at least 24 hours before coronary intervention.</p>
      <p>The angiographic characteristics of the included patients are shown on <xref ref-type="table" rid="en_aop5278tab02-body2">Table 2</xref>. Most patients presented single-artery obstruction, and the artery most frequently treated was the anterior descendent artery. Regarding anatomic complexity, 57.7% of the lesions were classified as B2 or C according to ACC/AHA classification. Left ventricular function, according to global ejection fraction, was 57.8 &#177; 5.3%.</p>
      <p content-type="asset">
        <table-wrap id="en_aop5278tab02-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt02-en.jpg"/></table-wrap>
      </p>
      <p>The mean period of time between initial clinical presentation of the acute coronary syndrome and cinecoronariography performance was 6.1 &#177; 1.8 days, and 8.2 &#177; 2.5 days for the percutaneous coronary intervention. Regarding the procedure's technical characteristics, 38% of the lesions were dilated previously to stent implantation. Stent post-dilation was performed in 90% of the patients.</p>
      <p>
        <bold>Hospital and 30-day outcomes</bold>
      </p>
      <p>All the 52 included patients were submitted to coronary intervention with clinical and angiographic success, and were discharged after a mean period of 1.32 &#177; 0.86 days. Thirty days after the procedure, the patients were submitted to the planned clinical, laboratorial and electrocardiographic evaluations. There were no cases of stent thrombosis, major cardiac events (death, infarct or stroke) or myocardial ischemia symptom recurrence in this period.</p>
      <p>
        <bold>Virtual Histology<sup>&#174;</sup> ultrasound evaluation</bold>
      </p>
      <p>Radiofrequency ultrasound results (Virtual Histology<sup>&#174;</sup>) are shown in <xref ref-type="table" rid="en_aop5278tab03-body2">table 3</xref>. According to the proposed classification, fibroatheroma and calcified fibroatheroma lesions predominated (61.5% of the total). Nine (17.3%) of the lesions were defined as thin-cap fibroatheromas.</p>
      <p content-type="asset">
        <table-wrap id="en_aop5278tab03-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gt03-en.jpg"/></table-wrap>
      </p>
      <p>Regarding the plaque components mean percentage, the fibrotic tissue was the predominant component (59.6 &#177; 15.8% of the total analyzed plaque volume); approximately 20% of the total lesion volume was composed by necrotic core. <xref ref-type="fig" rid="en_aop5278fig03-body2">Figure 3</xref> shows the median and interquartile intervals of the volumetric percentage of each one of the four atherosclerotic plaque components.</p>
      <p content-type="asset">
        <fig id="en_aop5278fig03-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf03-en.jpg"/></fig>
      </p>
      <p>
        <bold>Association of the atherosclerotic lesion characteristics according to Virtual Histology<sup>&#174;</sup> and C-reactive protein levels</bold>
      </p>
      <p>C-reactive protein basal levels of the patients included in this study were 16.02 &#177; 18.07 mg/l (reference value, &lt; 5 mg/l). No association was observed between the atherosclerotic lesion component percentage according to Virtual Histology<sup>&#174;</sup> findings and the inflammatory marker high sensitivity C-reactive protein measured before percutaneous coronary intervention. <xref ref-type="fig" rid="en_aop5278fig04-body2">Figure 4</xref> show the correlation graphics between different plaque components and pre-procedure C-reactive protein levels.</p>
      <p content-type="asset">
        <fig id="en_aop5278fig04-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf04-en.jpg"/></fig>
      </p>
      <p>The variation between this inflammatory marker basal levels and the levels observed 24 hours after the intervention (s &#916; CRP) was calculated as 3.18 &#177; 6.26 mg/L. As for the pre-intervention measurement, no correlation was detected between individual C-reactive protein variations and treated plaque components (<xref ref-type="fig" rid="en_aop5278fig05-body2">Figure 5</xref>).</p>
      <p content-type="asset">
        <fig id="en_aop5278fig05-body2">
          <graphic xlink:href="1678-4170-abc-101-01-0078-00042-gf05-en.jpg"/></fig>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>In our prospective study with acute coronary syndrome patients, the plaque composition according to Virtual Histology<sup>&#174;</sup> ultrasound was predominantly fibrotic, with a high percentage of the necrotic component. No correlation was found between the basal C-reactive protein levels (or the pre- and post-intervention level range) and the culprit atherosclerotic plaque composition in this series.</p>
      <p>Pathology studies demonstrate that the rupture of plaques with large necrotic and inflammatory cores and subsequent thrombosis are the main mechanisms that determine the occurrence of acute coronary syndrome. These findings correlate with Virtual Histology<sup>&#174;</sup> results. Using this method, Pundziute et al<sup>13 </sup>observed that the mean percentage of necrotic cores in the observed coronary lesions was significantly greater in acute coronary syndrome patients than in stable angina patients (11.2 &#177; 6.1% <italic>versus</italic> 9.1 &#177; 4.6%, p = 0.02). In an analysis of 318 cases, Hong et al<sup>14</sup> report that the culprit plaque morphology of patients with unstable clinical picture is distinct of the target lesions in stable patients: the necrotic core at the major lumen reduction point is larger (33% <italic>versus</italic> 29%, p = 0.015) and the fibrofatty tissue percentage is smaller (5% <italic>versus</italic> 7%, p = 0.020), respectively. Rodriguez-Granillo et al<sup>15</sup> demonstrated that the mean percentage of necrotic content is larger in the non-culprit lesions of patients with unstable syndromes than in the atherosclerotic plaques in stable patients (12.26% &#177; 7.0% <italic>versus</italic> 7.4 &#177; 5.5%), p &lt; 0.006), suggesting that the systemic pro-inflammatory status can influence not only the destabilization of culprit lesions but also the activation of quiescent lesion in other coronary sites. Surmely et at<sup>16</sup> report that, at least in the site with the smaller lumen diameter, the fibrotic component area can be larger in the plaques of patients with acute syndrome than in stable individuals (6.0 &#177; 10.7 <italic>versus</italic> 61.4 &#177; 8.9%, p = 0.034). In our study, most culprit lesions were classified as fibroatheromas or calcified fibroatheromas; great variation in plaque types was observed, and 17.3% were defined as thin-cap fibroatheromas. The fibrotic component (59.6% &#177; 15.8%) predominated in the analyzed lesions, which also showed a large percentage of necrotic cores (20.7% &#177; 12.7%).</p>
      <p>C-reactive protein, a laboratorial marker of the systemic inflammatory status, is also synthesized at the site of the atherosclerotic plaque, and would reflect the destabilization process<sup>7,8</sup>. Various studies searched to evaluate the association between C-reactive protein levels and atherosclerotic plaque characteristics at monochromatic intracoronary ultrasound. In a study with post-AMI patients, Sano et al<sup>17</sup> found a higher prevalence of lesions with rupture ultrasonographic changes, with positive remodeling or lipid lakes in individuals with high C-reactive protein levels, as compared to patients with normal levels of this marker. Hong et al<sup>18</sup>, on the other side, in a intracoronary ultrasound performed on the three main vessels, found that high C-reactive protein levels were the only predictors of ruptured plaques. In our investigation with radiofrequency intracoronary ultrasound, however, no association was found between the component percentage in the culprit plaque and the serum C-reactive protein levels. It is possible that, since only the lesions that had already suffered erosion or rupture were analyzed, part of the necrotic core had already embolized; consequently, the observation of a smaller percentage of this component may have led to the classification of some lesions as fibrotic and influenced the correlation with C-reactive protein levels. </p>
      <p>It is known that distal embolization of necrotic content and atherosclerotic plaque debris during percutaneous coronary intervention is associated to adverse clinical and angiographic outcomes. Virtual Histology<sup>&#174;</sup>is being investigated in this setting for the identification of lesions with higher complication risk. Various studies with STEMI AMI demonstrated that a higher percentage of the necrotic core in the treated plaques is associated to the development of electrocardiographic signs suggestive of non-reperfusion<sup>19</sup>, to no-reflow occurrence<sup>20</sup> and to the appearance of transient and high frequency signals at intracoronary Doppler<sup>21</sup> - indicating distal embolization. These complications may be accompanied by an increase in C-reactive protein levels. In our series, no ischemic complications related to the revascularization procedure occurred, and no association was detected between the component percentages in the culprit lesion and the C-reactive protein increase. Drug therapy started before the intervention (dual antiplatelet therapy, anti-thrombin drugs and statins) may explain the discrepancy between our study's findings and the ones previously reported. </p>
      <p>
        <bold>Limitations</bold>
      </p>
      <p>Some limitations of this study are related to the imaging method itself. First, since it is a technology based on ultrasound principles, Virtual Histology<sup>&#174;</sup> has a 100-&#181;m axial resolution and 250-&#181;m lateral resolution, which prevents the detection of plaques with thinner fibrotic plaques (&lt; 65 &#181;m), which have been pointed out as precursors of acute ischemic events. Moreover, not all plaque components are identified by the method: intraluminal thrombus, for example, is not included in contemporary classification algorithms. Thus, thrombotic tissue is automatically classified as a fibrous or fibrofatty component<sup>12</sup>. Due to it, the observation of images suggestive of thrombus at angiography (common in patients with acute syndromes) is one our study's exclusion criteria. Similarly to conventional intracoronary ultrasound, non-confluent calcium deposition does not lead to difficulties in the evaluation of the most profound plaque tissues. On the other side, due to the appearance of acoustic shadow, its confluent and organized disposition may reduce method accuracy for the recognition of other components.</p>
      <p>Naturally, this investigation's findings do not eliminate the potential indication of the imaging method in the numerous other possibilities for which it is being studied, among which we highlight: better understanding of coronary disease natural evoulaiton<sup>22,23</sup>; effects of drug therapies aiming for regression or stabilization of atherosclerotic plaques<sup>24-26</sup>; and correlation between the type and composition of lesions with percutaneous intervention results<sup>19-21,27</sup>.</p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>In our study, the composition of the plaques according to Virtual Histology<sup>&#174;</sup> ultrasound was predominantly fibrotic and had large necrotic core content. No correlation was found between the basal C-reactive protein levels (or the pre- and post-intervention level range) and the culprit atherosclerotic plaque composition in patients with acute coronary syndrome.</p>
      <p>
        <bold>Author contributions</bold>
      </p>
      <p>Conception and design of the research and Statistical analysis: Siqueira DAA, Costa Junior JR; Acquisition of data: Siqueira DAA, Costa Junior JR, Costa RA, Staico R, Tanajura LFL, Centemero MP, Feres F, Abizaid AAC; Analysis and interpretation of the data: Siqueira DAA, Sousa AGMR, Costa Junior JR; Obtaining funding: Siqueira DAA, Sousa AGMR, Abizaid AAC; Writing of the manuscript: Siqueira DAA; Critical revision of the manuscript for intellectual content: Siqueira DAA, Sousa AGMR, Costa RA, Staico R, Tanajura LFL, Abizaid AAC, Sousa JEMR.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by CAPES.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of doctoral submitted by Dimytri Alexandre de Alvim Siqueira, from Instituto Dante Pazzanese de Cardiologia an organization associated with Universidade de S&#227;o Paulo - USP.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
